- Home
- PSEC vs INVA Comparison
PSEC vs INVA Comparison
Compare PSEC & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSEC
- INVA
- Stock Information
- Founded
- PSEC 2004
- INVA 1996
- Country
- PSEC United States
- INVA United States
- Employees
- PSEC N/A
- INVA N/A
- Industry
- PSEC Finance/Investors Services
- INVA Biotechnology: Pharmaceutical Preparations
- Sector
- PSEC Finance
- INVA Health Care
- Exchange
- PSEC Nasdaq
- INVA Nasdaq
- Market Cap
- PSEC 1.2B
- INVA 1.1B
- IPO Year
- PSEC 2004
- INVA 2004
- Fundamental
- Price
- PSEC $2.79
- INVA $17.72
- Analyst Decision
- PSEC Sell
- INVA Buy
- Analyst Count
- PSEC 1
- INVA 5
- Target Price
- PSEC $2.50
- INVA $35.60
- AVG Volume (30 Days)
- PSEC 3.4M
- INVA 808.7K
- Earning Date
- PSEC 11-07-2025
- INVA 11-06-2025
- Dividend Yield
- PSEC 19.64%
- INVA N/A
- EPS Growth
- PSEC N/A
- INVA N/A
- EPS
- PSEC N/A
- INVA 0.53
- Revenue
- PSEC $719,436,000.00
- INVA $370,229,000.00
- Revenue This Year
- PSEC N/A
- INVA $7.98
- Revenue Next Year
- PSEC N/A
- INVA $11.60
- P/E Ratio
- PSEC N/A
- INVA $33.24
- Revenue Growth
- PSEC N/A
- INVA 12.02
- 52 Week Low
- PSEC $2.57
- INVA $16.52
- 52 Week High
- PSEC $5.33
- INVA $22.00
- Technical
- Relative Strength Index (RSI)
- PSEC 53.52
- INVA 46.00
- Support Level
- PSEC $2.68
- INVA $16.52
- Resistance Level
- PSEC $2.81
- INVA $18.45
- Average True Range (ATR)
- PSEC 0.07
- INVA 0.52
- MACD
- PSEC 0.00
- INVA 0.15
- Stochastic Oscillator
- PSEC 66.67
- INVA 52.86
About PSEC Prospect Capital Corporation
Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests mainly in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.